Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766893 · ClinicalTrials.gov registry record · Early Phase 1
Medication Maintenance Therapy in Community Pharmacy Settings
A Early Phase 1 study, sponsored by Lifespan.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT03766893: Completed Early Phase 1 study, sponsored by Lifespan.
NCT03766893 is a Early Phase 1 study that has completed, run by Lifespan. The registered enrollment target is 11 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03766893, a Early Phase 1 study, has completed, sponsored by Lifespan.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.
Primary Outcome
Measured by the number of MAT medications dispensed from a study pharmacy according to the pharmacy records, over the one month pilot period.
Interventions
- DRUG Buprenorphine / Naloxone Oral Product
- DRUG injectable naltrexone
- OTHER Pharmacy maintenance addiction care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2018-12-31 |
| Phase | Early Phase 1 |
What the finished NCT03766893 record still lists
NCT03766893 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine / Naloxone Oral Product is the first listed.
NCT03766893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03766893 about?
NCT03766893 is a clinical study titled "Medication Maintenance Therapy in Community Pharmacy Settings". The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.
What is the current status of trial NCT03766893?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2018-09-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03766893?
The interventions under investigation include: Buprenorphine / Naloxone Oral Product (DRUG), injectable naltrexone (DRUG), Pharmacy maintenance addiction care (OTHER).
Who is sponsoring clinical trial NCT03766893?
This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03766893's enrollment target sits among peer trials
11 1601st of 2000 higher than 373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI